Search results
Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
Motley Fool via Yahoo Finance· 4 days agoThe compounding effect of dividend reinvestment over enough time can potentially make it possible to...
A Closer Look at Bristol-Myers Squibb's Options Market Dynamics - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 1 week agoLoading... Loading... Financial giants have made a conspicuous bearish move on Bristol-Myers Squibb. Our analysis of options history for Bristol-Myers Squibb BMY revealed ...
Mather Group LLC. Boosts Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 6 days agoMather Group LLC. grew its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 7.1% in the 4th quarter, according to its most recent filing with the Securities ...
India's Dr Reddy's beats Q4 profit view; names new CFO
Reuters· 4 hours agoIndia's generic drugmaker Dr Reddy's Laboratories reported fourth-quarter profit above expectations on Tuesday on higher U.S. and Europe sales, and appointed its new chief financial officer.
Insider Buying: BOERNER CHRISTOPHER S., Bristol-Myers Squibb Co. [BMY] Chief Executive Officer...
Knox Daily· 5 days agoAs published in a research note from Societe Generale on March 11, 2024, Bristol-Myers Squibb Co. [BMY] has been rated down from a Buy to a Hold. Analysts at Redburn Atlantic ...
Uncover the Potential: 3 Discounted Stocks Ready for a Comeback
InvestorPlace· 1 day agoIn some situations, a discount may become a permanent trading price range unless the company has a catalyst in the works. As such, the stocks discussed in this article are those that may be ...
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
Morningstar· 6 days agoEditas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced a two-year extension to the collaboration with Bristol Myers Squibb (NYSE: BMY ...
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Zacks via Yahoo Finance· 5 days agoThis upgrade came after the company won the Zejula royalty dispute appeal that resulted in higher...
Pharma R&D productivity seen improving for the first time in years
Seeking Alpha· 3 days agoDiscover the latest findings on the return on investment from pharmaceutical...
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Zacks· 5 days agoFree Report) and GSK plc (GSK Quick QuoteGSK - Free Report) . Mergers and acquisitions continue to be in the spotlight as pharma and biotech majors look to bolster their product portfolio/pipeline ...